Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
Lyle Feinstein(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ute Hegenbart(Heidelberg University), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), Michael B. Maris(Colorado Blood Cancer Institute), David G. Maloney(Fred Hutch Cancer Center), Theodore A. Gooley(Leipzig University), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 93
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k